EHR-based case finding identified 21.5% of coded PV patients with hematocrit above the <45% target, enabling intervention ...
Policy makers should vet the methodology behind reported cost savings before trusting the numbers, says Halima ...
Jubril Oyeyemi, MD, FHELA, serves as the chief medical officer of Camden Coalition of Health Care Providers, the medical ...
The FDA has approved oveporexton (Orzeyful), the first orexin agonist for narcolepsy type 1, based on phase 3 data showing ...
Drugs that form the backbone of CLL therapy are also used across lymphoma subtypes, explains Adam S. Kittai, MD. The ...
More prediabetes screening, earlier GLP-1/SGLT2 inhibitor use, and broader CGM access in type 2 diabetes are needed, says ...
Marc A. Sala, MD, explains why long COVID overlaps with respiratory disease and how multidisciplinary care improves diagnosis ...
Marc A. Sala, MD, discusses bronchiectasis awareness gaps, care strategies, and the importance of cross-specialty ...
Here are 5 things stakeholders should know about the debate over establishing legitimate peptide regulations. Kennedy ...
Building the Multidisciplinary Care Model That MASH Patients Need,' the Jaime Almandoz, MD delves into the following critical ...
Almandoz explained that while GLP-1 receptor agonism alone delivers meaningful benefits in appetite regulation, satiety, ...
These findings, gleaned from the Children’s Health in London and Luton study, potentially offer new evidence that a clean air ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results